Jeffrey T. Jensen, M.D., M.P.H.

  • Professor of Obstetrics and Gynecology, School of Medicine
  • Professor, Oregon National Primate Research Center
  • Vice-Chair of Research, Obstetrics and Gynecology, School of Medicine
  • Director of the Women's Health Research Unit, Center for Women's Health, School of Medicine

Biography

Jeffrey T. Jensen, M.D., M.P.H. is the Leon Speroff Professor and Vice Chair for Research in the Department of Ob/Gyn, Professor of Public Health and Preventive Medicine at OHSU and a Core Scientist at the Oregon National Primate Research Center (ONPRC). Dr. Jensen received a B.S. in Biology from Stanford University, an MD from Emory University and his M.P.H. from the University of Washington. He completed an internship at Santa Clara Valley Medical Center and a residency in obstetrics and gynecology at OHSU. Following residency training, he served four years in the United States Navy, and joined the faculty at OHSU in 1992.

Dr. Jensen’s career has been devoted to the improvement of human health and society through the promotion of safe, effective methods of contraception so that every baby is wanted and planned. As a clinician-scientist with more than 20 years of experience, his efforts encompass clinical care, clinical research and translational research.

He is the Director of the Women’s Health Research Unit at OHSU, and PI of the NICHD-funded Contraception Clinical Trials Network (CCTN). At ONPRC, he is Director of the Bill & Melinda Gates Foundation-funded Oregon Permanent Contraception Research Center (OPERM). His lab investigates novel contraceptive strategies using the nonhuman primate model. Current projects include the identification of oocyte-specific contraceptive agents, and nonsurgical methods of permanent contraception. He collaborates with CONRAD, FHI360, and the Population Council. He has served as a consultant or on advisory boards for several pharmaceutical companies including Abbvie, Agile Pharmaceuticals, Bayer Healthcare, CooperSurgical, Evofem, Merck, HRA Pharma, MicroChips, ContraMed, and Wyeth. He is a well-regarded international speaker on contraception and serves as a Deputy Editor for the journal Contraception.

Education

  • M.D., 1980, Emory University
  • M.P.H., 1997, University of Washington
  • Internship:

    • Santa Clara Valley Medical Center, Flexible, 1985
  • Residency:

    • Obstetrics and gynecology, Oregon Health & Science University, 1988
  • Certifications:

    • American Board of Obstetrics and Gynecology

Memberships and associations

  • American Congress of Obstetricians and Gynecologists

Publications

Elsevier pure profile

Selected publications

  • Jensen JT, Schwinof KM, Zelinski-Wooten MB, Conti M, DePaolo LV, Stouffer RL. Phosphodiesterase 3 inhibitors selectively block the spontaneous resumption of meiosis by macaque oocytes in vitro. Hum Reprod. 2002; 17:2079-2784. PMID: 12151440
  • Jensen JT, Stouffer RL, Stanley JE, Zelinski MB. Evaluation of the phosphodiesterase 3 inhibitor ORG 9935 as a contraceptive in female macaques: initial trials. Contraception. 2010; 81:165-171. PMCID: PMC2813210
  • Hanna CB, Yao S, Patta MC, Jensen JT, Wu X. Expression of insulin-like 3 (INSL3) and differential splicing of its receptor in the ovary of rhesus macaques. Reprod Biol Endocrinol. 2010; 8:150. PMCID: PMC3008693
  • Hanna CB, Yao S, Martin M, Schönbrunn E, Georg GI, Jensen JT, et al. Identification and Screening of Selective WEE2 Inhibitors to Develop Non-Hormonal Contraceptives that Specifically Target Meiosis. ChemistrySelect. 2019;4(45):13363-9. PMCID: PMC7079731
  • Zhu JY, Cuellar RA, Berndt N, Lee HE, Olesen SH, Martin MP, Jensen JT, et al. Structural Basis of Wee Kinases Functionality and Inactivation by Diverse Small Molecule Inhibitors. J Med Chem. 2017;60(18):7863-75. PMCID: PMC6200136
  • Jensen JT, Hanna C, Yao S, Thompson E, Bauer C, Slayden OD. Transcervical administration of polidocanol foam prevents pregnancy in female baboons. Contraception. 2016; 94:527-533. PMCID: PMC5083254
  • Jensen JT, Hanna C, Yao S, Bauer C, Morgan TK, Slayden OD. Characterization of tubal occlusion after transcervical polidocanol foam (PF) infusion in baboons. Contraception. 2015; 92:96-102. PMCID: PMC4521910
  • Jensen JT, Hanna C, Yao S, Micks E, Edelman A, Holden L, Slayden OD. Blockade of tubal patency following transcervical administration of polidocanol foam: initial studies in rhesus macaques. Contraception. 2014; 89:540-549. PMCID: PMC4033706
  • Jensen JT, Edelman AB, Chen BA, Archer DF, et al. Continuous dosing of a novel contraceptive vaginal ring releasing Nestorone(R) and estradiol: pharmacokinetics from a dose-finding study. Contraception. 2018;97(5):422-7. PMCID: PMC5948142 
  • Edelman AB, Cherala G, Blue SW, Erikson DW, Jensen JT. Impact of obesity on the pharmacokinetics of levonorgestrel-based emergency contraception: single and double dosing. Contraception. 2016; 94:52-57. PMC4944814

Publications

  • {{ pub.journalAssociation.journal.name.text[0].value }}